Enveric Biosciences (ENVB) Short Interest Ratio & Short Volume $0.91 -0.10 (-9.90%) Closing price 04:00 PM EasternExtended Trading$0.93 +0.02 (+1.76%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Enveric Biosciences Short Interest DataEnveric Biosciences (ENVB) has a short interest of 232,400 shares, representing 8.24% of the float (the number of shares available for trading by the public). This marks a -8.90% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.4, indicating that it would take 1.4 days of the average trading volume of 312,654 shares to cover all short positions.Current Short Interest232,400 sharesPrevious Short Interest255,100 sharesChange Vs. Previous Month-8.90%Dollar Volume Sold Short$255.64 thousandShort Interest Ratio1.4 Days to CoverLast Record DateAugust 15, 2025Outstanding Shares3,250,000 sharesFloat Size2,820,000 sharesShort Percent of Float8.24%Today's Trading Volume162,774 sharesAverage Trading Volume312,654 sharesToday's Volume Vs. Average52% Short Selling Enveric Biosciences? Sign up to receive the latest short interest report for Enveric Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartENVB Short Interest Over TimeENVB Days to Cover Over TimeENVB Percentage of Float Shorted Over Time Enveric Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/2025232,400 shares $255.64 thousand -8.9%8.2%1.4 $1.10 7/31/2025255,100 shares $311.22 thousand +19.5%11.9%1 $1.22 7/15/2025213,500 shares $262.61 thousand -20.6%10.0%0.9 $1.23 6/30/2025269,000 shares $325.49 thousand +17.8%12.6%1.3 $1.21 6/15/2025228,400 shares $276.36 thousand -25.0%10.7%1.1 $1.21 5/31/2025304,600 shares $356.41 thousand +143.3%14.2%1.5 $1.17 5/15/2025125,200 shares $157.75 thousand -27.2%5.9%0 $1.26 4/30/2025172,000 shares $227.04 thousand -1.3%7.0%0.1 $1.32 4/15/2025174,200 shares $216.48 thousand -3.0%7.5%0.1 $1.24 3/31/2025179,500 shares $249.51 thousand -25.6%7.7%0.1 $1.39 Get the Latest News and Ratings for ENVB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter. 3/15/2025241,100 shares $417.10 thousand -80.6%13.3%0.1 $1.73 2/28/20251,240,000 shares $3.47 million +351.4%77.5%0.5 $2.80 2/15/2025274,700 shares $439.52 thousand +17.8%15.2%0.1 $1.60 1/31/2025233,200 shares $487.39 thousand -42.8%16.9%1.5 $2.09 1/15/2025407,400 shares $145.44 thousand +498.2%4.3%0.8 $0.36 12/31/202468,100 shares $24.41 thousand -56.7%0.7%0.1 $0.36 12/15/2024157,200 shares $57.14 thousand +36.1%1.7%0.3 $0.36 11/30/2024115,500 shares $38.12 thousand -57.6%1.2%0.2 $0.33 11/15/2024272,200 shares $100.71 thousand -17.6%3.0%0.5 $0.37 10/31/2024330,200 shares $164.84 thousand +70.9%4.1%0.7 $0.50 10/15/2024193,200 shares $81.72 thousand -2.9%2.4%0.1 $0.42 9/30/2024199,000 shares $94.33 thousand -2.8%2.3%0.2 $0.47 9/15/2024204,700 shares $102.55 thousand -38.3%2.3%0.2 $0.50 8/31/2024332,000 shares $168.46 thousand -29.2%3.8%0.3 $0.51 8/15/2024469,100 shares $226.58 thousand -80.9%5.3%0.4 $0.48 7/31/20242,450,000 shares $1.15 million +1,760.3%31.2%1.7 $0.47 7/15/2024131,700 shares $71.38 thousand -13.4%1.7%0.2 $0.54 6/30/2024152,100 shares $95.25 thousand -43.4%2.0%0.3 $0.63 6/15/2024268,800 shares $198.91 thousand -20.5%3.5%0.5 $0.74 5/31/2024338,100 shares $263.72 thousand -50.2%4.5%0.2 $0.78 5/15/2024678,900 shares $534.97 thousand +736.1%8.9%0.1 $0.79 4/30/202481,200 shares $76.33 thousand -15.1%1.1%0 $0.94 4/15/202495,600 shares $88.10 thousand -62.5%1.4%0 $0.92 3/31/2024254,900 shares $254.90 thousand +69.5%4.2%0.1 $1.00 3/15/2024150,400 shares $162.43 thousand +58.2%3.2%0 $1.08 2/29/202495,100 shares $137.90 thousand +47.0%4.2%0 $1.45 2/15/202464,700 shares $54.28 thousand +181.3%2.5%0.2 $0.84 1/31/202423,000 shares $16.93 thousand -58.6%0.9%0.2 $0.74 1/15/202455,600 shares $71.17 thousand +334.4%2.3%1.4 $1.28 12/31/202312,800 shares $16.64 thousand +6.7%0.6%0.4 $1.30 12/15/202312,000 shares $16.08 thousand +263.6%0.6%0.7 $1.34 11/30/20233,300 shares $4.88 thousand -54.8%0.2%0.2 $1.48 11/15/20237,300 shares $10.40 thousand -62.4%0.4%0.4 $1.43 10/31/202319,400 shares $33.37 thousand -19.5%1.0%0.9 $1.72 10/15/202324,100 shares $50.85 thousand +121.1%1.3%0.3 $2.11 9/30/202310,900 shares $25.94 thousand -55.0%0.6%0.1 $2.38 9/15/202324,200 shares $55.18 thousand -45.3%1.2%0.3 $2.28 8/31/202344,200 shares $95.47 thousand -42.3%2.3%0.4 $2.16 8/15/202376,600 shares $182.31 thousand +86.4%4.0%0.1 $2.38 7/31/202341,100 shares $109.74 thousand +95.7%2.2%0 $2.67 7/15/202321,000 shares $60.27 thousand -43.1%1.1%0 $2.87 6/30/202336,900 shares $124.35 thousand -65.6%2.0%0 $3.37 6/15/2023107,400 shares $414.56 thousand -69.1%5.8%0 $3.86 5/31/2023347,300 shares $1.46 million +1,430.0%18.7%0.1 $4.19 5/15/202322,700 shares $34.05 thousand -30.2%1.2%0 $1.50 4/30/202332,500 shares $59.52 thousand +44.4%1.8%1 $1.83 4/15/202322,500 shares $34.20 thousand +39.8%1.2%0.6 $1.52 3/31/202316,100 shares $26.79 thousand +64.3%0.9%0.6 $1.66 3/15/20239,800 shares $16.95 thousand +71.9%0.6%0.3 $1.73 2/28/20235,700 shares $11.91 thousand -38.0%0.3%0.1 $2.09 2/15/20239,200 shares $24.93 thousand -37.8%0.5%0.2 $2.71 1/31/202314,800 shares $42.48 thousand -53.6%0.8%0.3 $2.87 1/15/202331,900 shares $90.28 thousand -21.2%1.7%0.7 $2.83 12/30/202240,500 shares $84.24 thousand -11.2%2.0%0.7 $2.08 12/15/202245,600 shares $97.58 thousand +27.4%2.3%0.9 $2.14 11/30/202235,800 shares $102.75 thousand -17.5%1.8%0.5 $2.87 11/15/202243,400 shares $147.56 thousand -37.7%2.2%0.4 $3.40 10/31/202269,700 shares $237.68 thousand +36.1%4.7%0.3 $3.41 10/15/202251,200 shares $175.10 thousand +55.2%3.6%0.1 $3.42 9/30/202233,000 shares $139.26 thousand -60.1%2.3%0.1 $4.22 9/15/202282,800 shares $477.76 thousand +11.7%5.8%0.2 $5.77 8/31/202274,100 shares $413.48 thousand -21.7%5.4%0.2 $5.58 8/15/202294,600 shares $624.36 thousand -43.4%6.9%0.2 $6.60 7/31/2022167,000 shares $1.07 million +158.5%16.7%0.6 $6.40 7/15/202264,600 shares $25.71 million +36.6%7.5%0.8 $398.00 6/30/20222,360,000 shares $505.75 thousand -23.9%N/A0.9 $0.21 6/15/20223,100,000 shares $651 thousand -4.6%N/A1.6 $0.21 5/31/20223,250,000 shares $642.53 thousand -2.1%N/A1.5 $0.20 5/15/20223,320,000 shares $664 thousand -2.4%N/A1.1 $0.20 4/30/20223,400,000 shares $918.34 thousand +165.6%N/A1 $0.27 4/15/20221,280,000 shares $384.38 thousand -19.5%N/A0.4 $0.30 3/31/20221,590,000 shares $524.70 thousand -17.6%N/A0.6 $0.33 3/15/20221,930,000 shares $536.54 thousand +498.1%N/A0.8 $0.28 2/28/2022322,700 shares $88.58 thousand -67.6%N/A0.1 $0.27 2/15/2022996,300 shares $313.83 thousand +421.9%N/A0.8 $0.32 1/31/2022190,900 shares $121.47 thousand -67.1%N/A0.3 $0.64 1/15/2022580,200 shares $434.45 thousand +143.0%N/A0 $0.75 12/31/2021238,800 shares $222.08 thousand -41.9%N/A0.3 $0.93 12/15/2021411,300 shares $435.98 thousand -50.8%N/A0.3 $1.06 11/30/2021835,400 shares $1.09 million -45.0%4.0%0.4 $1.30 11/15/20211,520,000 shares $2.74 million -22.5%7.3%0.4 $1.80 10/29/20211,960,000 shares $3.45 million +16.0%13.8%0.5 $1.76 10/15/20211,690,000 shares $3.19 million +33.1%10.9%0.5 $1.89 9/30/20211,270,000 shares $2.63 million -44.5%8.2%0.4 $2.07 9/15/20212,290,000 shares $6.07 million +178.1%14.2%0.7 $2.65 8/31/2021823,600 shares $1.64 million -5.0%5.1%0.3 $1.99 8/13/2021866,800 shares $1.49 million -9.4%5.4%0.7 $1.72 7/30/2021956,800 shares $1.83 million +8.2%5.9%0.7 $1.91 7/15/2021884,400 shares $1.82 million +17.3%5.5%0.6 $2.06 6/30/2021754,300 shares $1.80 million +37.8%4.7%0.5 $2.38 6/15/2021547,600 shares $1.21 million -48.3%3.4%0.3 $2.21 5/28/20211,060,000 shares $2.36 million +183.1%6.5%0.4 $2.23 5/14/2021374,400 shares $711.36 thousand -30.3%2.3%0.1 $1.90 4/30/2021536,900 shares $1.33 million -41.1%3.4%0.1 $2.48 4/15/2021911,800 shares $2.28 million +17.5%5.7%0.1 $2.50 3/31/2021776,000 shares $2.30 million +34.6%5.6%0.1 $2.97 3/15/2021576,400 shares $2.13 million +233.8%4.1%0.1 $3.70 2/26/2021172,700 shares $628.63 thousand -9.4%2.0%0.1 $3.64 2/12/2021190,700 shares $928.71 thousand +110.0%2.2%0.1 $4.87 1/29/202190,800 shares $345.95 thousand -42.4%10.0%0.1 $3.81 1/15/2021157,700 shares $657.61 thousand No Change17.4%0.2 $4.17 ENVB Short Interest - Frequently Asked Questions What is Enveric Biosciences' current short interest? Short interest is the volume of Enveric Biosciences shares that have been sold short but have not yet been covered or closed out. As of August 15th, investors have sold 232,400 shares of ENVB short. 8.24% of Enveric Biosciences' shares are currently sold short. Learn More on Enveric Biosciences' current short interest. What is a good short interest ratio for Enveric Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ENVB shares currently have a short interest ratio of 1.0. Learn More on Enveric Biosciences's short interest ratio. What is a good short interest percentage for Enveric Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.24% of Enveric Biosciences' floating shares are currently sold short. Is Enveric Biosciences' short interest increasing or decreasing? Enveric Biosciences saw a decrease in short interest in the month of August. As of August 15th, there was short interest totaling 232,400 shares, a decrease of 8.9% from the previous total of 255,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Enveric Biosciences' float size? Enveric Biosciences currently has issued a total of 3,250,000 shares. Some of Enveric Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Enveric Biosciences currently has a public float of 2,820,000 shares. How does Enveric Biosciences' short interest compare to its competitors? 8.24% of Enveric Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Enveric Biosciences: ProPhase Labs, Inc. (6.14%), Soligenix Inc. (6.18%), NextCure, Inc. (3.83%), Longeveron Inc. (10.29%), Flora Growth Corp. (2.38%), TherapeuticsMD, Inc. (0.22%), BioVie Inc. (2.21%), Bullfrog AI Holdings Inc. (3.94%), Leap Therapeutics, Inc. (5.18%), HCW Biologics Inc. (2.34%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Lucid Group, Inc. ($8.00 billion), Spotify Technology ($5.48 billion), AppLovin Corporation ($5.11 billion), Reddit Inc. ($5.02 billion), Coinbase Global, Inc. ($3.99 billion), Charter Communications, Inc. ($3.89 billion), Live Nation Entertainment, Inc. ($3.18 billion), Seagate Technology Holdings PLC ($2.59 billion), ResMed Inc. ($2.55 billion), and Rocket Lab Corporation ($2.52 billion). View all of the most shorted stocks. What does it mean to sell short Enveric Biosciences stock? Short selling ENVB is an investing strategy that aims to generate trading profit from Enveric Biosciences as its price is falling. ENVB shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Enveric Biosciences? A short squeeze for Enveric Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ENVB, which in turn drives the price of the stock up even further. How often is Enveric Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENVB, twice per month. The most recent reporting period available is August, 15 2025. More Short Interest Resources from MarketBeat Related Companies ProPhase Labs Short Interest Soligenix Short Interest NextCure Short Interest Longeveron Short Interest Flora Growth Short Interest TherapeuticsMD Short Interest BioVie Short Interest Bullfrog AI Short Interest Leap Therapeutics Short Interest HCW Biologics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ENVB) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enveric Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enveric Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
